U.S. Research Roundup-Abbvie, Amazon, Illumina
SPY•Publication note
(Compiled by Bengaluru Newsroom)
Additional research actions
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
The list includes multiple target-price increases and cuts, as well as several rating changes and initiations across sectors including healthcare, technology, financials, consumer staples, energy, industrials and real estate. The article continues with company-by-company analyst actions in alphabetical order.
Key target-price changes highlighted by Reuters
- Abbvie ABBV.N: JP Morgan raises target price to $285 from $280
- Amazon AMZN.O: Roth MKM raises target price to $325 from $300
- Illumina Inc ILMN.O: Piper Sandler raises target price to $225 from $200
- Colgate-Palmolive Co CL.N: Piper Sandler raises target price to $98 from $96
- Principal Financial Group Inc PFG.O: Jefferies raises target price to $102 from $98
Wall Street analysts revise targets on U.S.-listed companies
Aug. 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Amazon and Illumina on Monday.
